There are many genetic and acquired risk factors that are known to cause venous
thromboembolic disorders (VTE). One of these is the Prothrombin G20210A mutation, which …

We conducted a systematic and comprehensive meta-analysis on all candidate genes to
assess their genetic contribution to the aetiology of venous thromboembolism …

Distribution of hereditary thrombophilic gene mutations differs globally. Prothrombin gene
mutation G20210A is a common prothrombotic single-nucleotide polymorphism. In this …

Introduction A wide variety of non-genetic and genetic factors have been shown to associate
with increased risk for cerebral venous thrombosis (CVT). However, there is a paucity of risk …

Protein C (PC) and protein S (PS) are vitamin K-dependent glycoproteins that play an
important role in the regulation of blood coagulation as natural anticoagulants. PC is …

Venous thromboembolism (VTE) is a universal health hazard. Inherited and acquired risk
factors increase the risk of VTE. We evaluated the relationship between factor V (G1691A …

The aim of present study was to investigate the prevalence of factor V Leiden (FVL) c.
1691G> A, prothrombin g. 20210G> A and methylenetetrahydrofolate reductase (MTHFR) c …

This systematic review and meta-analysis assesses venous thromboembolism (VTE) risk in
adults with hereditary thrombophilia, including Factor V Leiden (FVL) mutation, prothrombin …

Background and objective: Thrombotic and microangiopathic effects have been reported in
Coronavirus Disease-2019 (COVID-19) patients. In the present study, we aimed to examine …

Background: Factor V G1691A (FV Leiden), FII GA20210, and methylenetetrahydrofolate
reductase (MTHFR) C677T mutations are the most common genetic risk factors for …